Cancer Institute– A national cancer institute
designated cancer center

Ranjana Advani

Back to Profile

Publication Details

  • A Phase I Trial of Aprinocarsen (ISIS 3521/LY900003), an Antisense Inhibitor of Protein Kinase C-alpha Administered as a 24-hour Weekly Infusion Schedule in Patients with Advanced Cancer.

    Advani R, Lum BL, Fisher GA, Halsey J, Geary RS, Holmlund JT, Kwoh TJ, Dorr FA, and Sikic BI.. Investigational New Drugs,. 2005 In Press

Stanford Medicine Resources:

Footer Links: